Drugs to suppress cough

Expert Opinion on Investigational Drugs

Volumn 14, Issue 1, 2005, Pages 19-27

  Chung, K F ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Antitussive; Cough; Cough receptor; Cough reflex; Opioids

Indexed keywords

1 (1 CYCLOOCTYLMETHYL 3 HYDROXYMETHYL 4 PIPERIDYL) 3 ETHYL 1,3 DIHYDRO 2H BENZIMIDAZOL 2 ONE; 3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; ACETYLCYSTEINE; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTITUSSIVE AGENT; BROMHEXINE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CANNABINOID; CARBOCISTEINE; CODEINE; CORTICOSTEROID; DECONGESTIVE AGENT; DELTA OPIATE RECEPTOR AGONIST; DEXTROMETHORPHAN; DIAMORPHINE; HISTAMINE H2 RECEPTOR ANTAGONIST; ICATIBANT; IPRATROPIUM BROMIDE; KAPPA OPIATE RECEPTOR AGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MECYSTEINE; MORPHINE; NEUROKININ; NOCICEPTIN; OPIATE; POTASSIUM CHANNEL STIMULATING AGENT; PROTON PUMP INHIBITOR; SODIUM CHANNEL BLOCKING AGENT; UNINDEXED DRUG; VANILLOID RECEPTOR;

ASTHMA; BLOOD BRAIN BARRIER; BRAIN FUNCTION; BREATHING REFLEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COLIC; CONSTIPATION; COUGHING; DEPRESSION; DISEASE ASSOCIATION; DROWSINESS; DRUG DEPENDENCE; DRUG EFFICACY; DRUG MECHANISM; GASTROESOPHAGEAL REFLUX; HUMAN; LUNG CANCER; NAUSEA; NOCICEPTIVE RECEPTOR; NONHUMAN; RESPIRATION DEPRESSION; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; REVIEW; RHINOSINUSITIS; SEDATION; SENSORY NERVE; VIRUS INFECTION;

ANTITUSSIVE AGENTS; COUGH; DRUGS, INVESTIGATIONAL; HUMANS;

EID: 12744255446     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.14.1.19     Document Type: Review

References (90)

1. CULLINAN P: Persistent cough and sputum: prevalence and clinical characteristics in south east England. Respir. Med. (1992) 86:143-149.
2. CHUNG KF, LALLOO UG: Diagnosis and management of chronic persistent dry cough. Postgrad. Med. J. (1996) 72:594-598.
3. FRENCH CL, IRWIN RS, CURLEY FJ, KRIKORIAN CJ: Impact of chronic cough on quality of life.. Arch. Intern. Med. (1998) 158 1657-1661.
4. WIDDICOMBE JG: Neurophysiology of the cough reflex. Eur. Respir. J. (1995) 8:1193-1202.
5. KARLSSON JA, SANT'AMBROGIO G, WIDDICOMBE J: Afferent neural pathways in cough and reflex bronchoconstriction. J. Appl. Physiol. (1988) 65:1007-1023.
6. FOX AJ: Modulation of cough and airway sensory fibres. Pulm. Pharmacol. (1996) 9:335-342.
7. CANNING BJ, MAZZONE SB, MEEKER SN, MORI N, REYNOLDS SM, UNDEM BJ: Identification of the tracheal and laryngeal afferent neurones mediating cough in anaesthetized guinea-pigs. J. Physiol. (2004) 557:543-558.
8. HANACEK J, DAVIES A, WIDDICOMBE JG: Influence of lung stretch receptors on the cough reflex in rabbits. Respiration (1984) 45 161-168.
9. JORDAN D: Central nervous pathways and control of the airways. Respir. Physiol. (2001) 125:67-81.
10. HUTCHINGS HA, MORRIS S, ECCLES R, JAWAD MS: Voluntary suppression of cough induced by inhalation of capsaicin in healthy volunteers. Respir. Med. (1993) 87:379-382.
11. CHOUDRY NB, FULLER RW: Sensitivity of the cough reflex in patients with chronic cough. Eur. Respir. J. (1992) 5 296-300.
12. CANNING B J: Interactions between vagal afferent nerve subtypes mediating cough. Pul. Pharmacol. Ther. (2002) 15 187-192.
13. MYERS AC, KAJEKAR R. UNDEM BJ: Allergic inflammation-induced neuropeptide production in rapidly adapting afferent nerves in guinea-pig airways. Am. J. Physiol. Lung Cell Mol. Physiol. (2002) 282 L775-L781.
14. MUTOH T, BONHAM AC, JOAD JP: Substance P in the nucleus of the solitary tract augments bronchopulmonary C fiber reflex output. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2000) 279 R1215-R1223.
15. MAZZONE SB, GERAGHTY DP: Respiratory action of capsaicin microinjected into the nucleus of the solitary tract: involvement of vanilloid and tachykinin receptors. Br. J. Pharmacol. (1999) 127 473-481.
16. NICHOL G, NIX A, BARNES PJ, CHUNG KF: Prostaglandin F2 α enhancement of capsaicin induced cough in man: modulation by α2 adrenergic and anticholinergic drugs. Thorax (1990) 45 694-698.
17. FOX AJ, LALLOO UG, BERNAREGGI M, BELVISI MG, CHUNG KF, BARNES PJ: Bradykinin and captopril-induced cough in guinea-pigs. Nat. Med. (1996) 814-817.
18. BRIGHTLING CE, WARD R, GOH KL, WARDLAW AJ, PAVORD ID: Eosinophilic bronchitis is an important cause of chronic cough. Am. J. Respir. Crit. Care Med. (1999) 160:406-410.
19. CHERIYAN S, GREENBERGER PA, PATTERSON R: Outcome of cough variant asthma treated with inhaled steroids. Ann. Allergy (1994) 73:478-480.
20. DICPINIGAITIS PV, DOBKIN JB: Effect of zafirlukast on cough reflex sensitivity in asthmatics. J. Asthma (1999) 36 265-270.
21. PRATTER MR, BARTTER T, AKERS S, DUBOIS J: An algorithmic approach to chronic cough. Ann. Intern. Med. (1993) 119 977-983.
22. SMYRNIOS NA, IRWIN RS, CURLEY FJ: Chronic cough with a history of excessive sputum production. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Chest (1995) 108:991-997
23. OURS TM, KAVURU MS, SCHILZ RJ, RICHTER JE: A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am. J. Gastroenterol. (1999) 94:3131-3138.
24. KILJANDER TO, SALOMAA ER, HIETANEN EK, TERHO EO: Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur. Respir. J. (2000) 16:633-638
25. NOVITSKY YW, ZAWACKI JK, IRWIN RS, FRENCH CT, HUSSEY VM, CALLERY MP: Chronic cough due to gastroesophageal reflux disease: efficacy of antireflux surgery. Surg. Endosc. (2002) 16 567-571.
26. DOHERTY MJ, MISTER R, PEARSON MG, CALVERLEY PM: Capsaicin induced cough in cryptogenic fibrosing alveolitis. Thorax (2000) 55:1028-1032.
27. AYLWARD M, MADDOCK J, DAVIES DE, PROTHEROE DA, LEIDEMAN T: Dextromethorphan and codeine: comparison of plasma kinetics and antitussive effects. Eur. J. Respir. Dis. (1984) 65:283-291.
28. EMPEY DW, LAITINEN LA, YOUNG GA, BYE CE, HUGHES DT: Comparison of the antitussive effects of codeine phosphate 20 mg, dextromethorphan 30 mg and noscapine 30 mg using citric acid-induced cough in normal subjects. Eur. J. Clin. Pharmacol. (1979) 16 393-397.
29. EDDY NB, FRIEBEL H, HAHN KJ, HALBACH H: Codeine and its alternates for pain and cough relief. 4. Potential alternates for cough relief. Bull World Health Organ. (1969) 40:639-719.
30. FREESTONE C, ECCLES R: Assessment of the antitussive efficacy of codeine in cough associated with common cold. J. Pharm. Pharmacol. (1997) 49:1045-1049.
31. MATTHYS H, BLEICHER B, BLEICHER U: Dextromethorphan and codeine: objective assessment of antitussive activity in patients with chronic cough. J. Int. Med. Res. (1983) 11:92-100.
32. PAVESI L, SUBBURAJ S, PORTER-SHAW K: Application and validation of a computerized cough acquisition system for objective monitoring of acute cough: a meta-analysis. Chest (2001) 120 1121-1128.
33. ADCOCK JJ, SCHNEIDER C, SMITH TW: Effects of codeine, morphine and a novel opioid pentapeptide BW443C, on cough, nociception and ventilation in the unanaesthetized guinea-pig. Br. J. Pharmacol. (1988) 93:93-100.
34. CHOUDRY NB, GRAY SJ, POSNER J, FULLER RW: The effect of 443C81, a mu opioid receptor agonist, on the response to inhaled capsaicin in healthy volunteers. Br. J. Clin. Pharmacol. (1991) 32:633-636.
35. KAMEI J, TANIHARA H, KASUYA Y: Antitussive effects of two specific κ-opioid agonists, U-50, 448H and U-62, 066E, in rats. Eur. J. Pharmacol. (1990) 199:281-286.
36. KOTZER CJ, HAY DW, DONDIO G, GIARDINA G, PETRILLO P, UNDERWOOD DC: The antitussive activity of δ-opioid receptor stimulation in guinea-pigs. J. Pharmacol. Exp. Ther. (2000) 292:803-809.
37. UENO S, SAITOH A, KAWAI K et al.: The rational drug design and antitussive effects of a novel opioid δ receptor antagonist TRK-851. Jap. J. Pharmacol. (2001) 85:S32-S34.
38. LAVEZZO A, MELILLO G, CLAVENNA G, OMINI C: Peripheral site of action of levodropropizine in experimentally-induced cough: role of sensory neuropeptides. Pulm. Pharmacol. (1992) 5:143-147.
39. SHAMS H, DAFFONCHIO L, SCHEID P: Effects of levodropropizine on vagal afferent C-fibres in the cat. Br. J. Pharmacol. (1996) 117:853-858.
40. CATENA E, DAFFONCHIO L: Efficacy and tolerability of levodropropizine in adult patients with non productive cough. Comparison with dextromethorphan. Pulm. Pharmacol. Ther. (1997) 10 89-96.
41. FISCHER A, FORSSMANN WG, UNDEM BJ: Nociceptin-induced inhibition of tachykinergic neurotransmission in guinea-pig bronchus. J. Pharmacol. Exp. Ther. (1998) 285:902-907.
42. SHAH S, PAGE CP, SPINA D: Nociceptin inhibits non-adrenergic non-cholinergic contraction in guinea-pig airway. Br. J. Pharmacol. (1998) 125:510-516.
43. CORBOZ MR, RIVELLI MA, EGAN RW et al.: Nociceptin inhibits capsaicin-induced bronchoconstriction in isolated guinea-pig lung. Eur. J. Pharmacol. (2000) 402:171-179.
44. McLEOD RL, PARRA LE, MUTTER JC et al.: Nociceptin inhibits cough in the guinea-pig by activation of ORL(1) receptors. Br. J. Pharmacol. (2001) 132:1175-1178
45. BOLSER DC, McLEOD RL, TULSHIAN DB, HEY JA: Antitussive action of nociceptin in the cat. Eur. J. Pharmacol. (2001) 430 107-111.
46. McLEOD RL, JIA Y, FERNANDEZ X et al.: Antitussive profile of the NOP agonist Ro-64-6198 in the guinea-pig. Pharmacology (2004) 71:143-149.
47. ROUGET C, CUI YY, D'AGOSTINO B et al.: Nociceptin inhibits airway microvascular leakage induced by HCl intra-oesophageal instillation. Br. J. Pharmacol. (2004) 141:1077-1083.
48. JIA Y, WANG X, APONTE SI et al.: Nociceptin/orphanin FQ inhibits capsaicin-induced guinea-pig airway contraction through an inward-rectifier potassium channel. Br. J. Pharmacol. (2002) 135 764-770.
49. GEPPETTI P, TOGNETTO M, TREVISANI M, AMADESI S, BERTRAND C: Tachykinins and kinins in airway allergy. Expert Opin. Invest Drugs (1999) 8:947-956.
50. ADVENIER C, GIRAUD V, NALINE E, VILLAIN P, EMONDS-ALT X: Antitussive effect of SR 48968, a non-peptide tachykinin NK2 receptor antagonist. Eur. J. Pharmacol. (1992) 250:169-173.
51. GIRARD V, NALINE E, VILAIN P, EMONDS-ALT X, ADVENIER C: Effect of the two tachykinin antagonists, SR 48968 and SR 140333, on cough induced by citric acid in the unanaesthetized guinea-pig. Eur. Respir. J. (1995) 8:1110-1114.
52. FAHY JV, WONG HH, GEPPETTI P et al.: Effect of an NK1 antagonist (CP-99,994) on hypertonis saline- induced bronchoconstriction and cough in male asthmatic subjects. Am. J. Resp. Crit. Care Med. (1995) 152:879-884.
53. HAY DW, GIARDINA GA, GRISWOLD DE et al.: Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea-pigs. J. Pharmacol. Exp. Ther. (2002) 300:314-323.
54. DAOUI S, COGNON C, NALINE E, EMONDS-ALT X, ADVENIER C: Involvement of tachykinin NK3 receptors in citric acid-induced cough and bronchial responses in guinea-pigs. Am. J. Respir. Crit. Care Med. (1998) 158:42-48.
55. BERGREN DR: Sensory receptor activation by mediators of defense reflexes in guinea-pig lungs. Respir. Physiol (1997) 108 195-204.
56. FEATHERSTONE RL, PARRY JE, EVANS DM et al.: Mechanism of irritant-induced cough: studies with a kinin antagonist and a kallikrein inhibitor. Lung (1996) 174:269-275.
57. FOX AJ, LALLOO UG, BERNAREGGI M, BELVISI MG, CHUNG KF, BARNES PJ: Bradykinin and captopril-induced cough in guinea-pigs. Nat. Med. (1996) 2:814-817.
58. BOCK MG, LONGMORE J: Bradykinin antagonists: new opportunities. Curr. Opin. Chem. Biol. (2000) 4:401-406
59. CATERINA MJ, SCHUMACHER MA, TOMINAGA M, ROSEN TA, LEVINE JD, JULIUS D: The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature (1997) 389:816-824.
60. LALLOO UG, FOX AJ, BELVISI MG, CHUNG KF, BARNES PJ: Inhibition by capsazepine of cough induced by capsaicin and citric acid, but not by hypertonic saline in awake guinea-pigs. J. Appl. Physiol. (1995) 79:1082-1087.
61. SZALLASI A, BLUMBERG PM: Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol. Rev. (1999) 51:159-212.
62. PREMKUMAR LS, AHERN GP: Induction of vanilloid receptor channel activity by protein kinase C. Nature (2000) 408 985-990.
63. GRONEBERG DA, NIIMI A, DINH QT et al.: Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough. Am. J. Respir. Crit. Care Med. (2004) [Epub ahead of print].
64. TREVISANI M, MILAN A, GATTI R et al.: Antitussive activity of iodoresiniferatoxin in guinea-pigs. Thorax (2004) 59 769-772.
65. GARCIA-MARTINEZ C, HUMET M, PLANELLS-CASES R et al.: Attenuation of thermal nociception and hyperalgesia by VR1 blockers. Proc. Natl. Acad. Sci. USA (2002) 99:2374-2379.
66. RAMI HK, THOMPSON M, WYMAN P et al.: Discovery of small molecule antagonists of TRPV1. Bioorg. Med. Chem. Lett. (2004) 14:3631-3634.
67. GORDON R, GORDON RJ, SOFIA D: Antitussive activity of some naturally occurring cannabinoids in anesthetized cats. Eur. J. Pharmacol. (1976) 35:309-313.
68. PATEL HJ, BIRRELL MA, CRISPINO N et al.: Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation. Br. J. Pharmacol. (2003) 140:261-268.
69. CALIGNANO A, KATONA I, DESARNAUD F et al.: Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature (2000) 408:96-101.
70. MORITA K, KAMEI J: Antitussive effect of WIN 55212-2, a cannabinoid receptor agonist. Eur. J. Pharmacol. (2003) 474 269-272.
71. FOX AJ, BARNES PJ, VENKATESAN P, BELVISI MG: Activation of large conductance potassium channels inhibits die afferent and efferent function of airway sensory nerves in the guinea-pig. J. Clin. Invest (1997) 99:513-519.
72. +) channels in the anti-tussive effect of moguisteine. Eur. J. Pharmacol. (2000) 395:161-164.
73. FOX AJ, URBAN L, BARNES PJ, DRAY A: Effects of casazepine against capsaicin- and proton-evoked excitation of single airway C-fibres and vagus nerve from the guinea-pig. Neurosci. Lett. (1995) 67 893-907.
74. SANT'AMBROGIO FB, SANT'AMBROGIO G, ANDERSON JW: Effect of furosemide on the response of laryngeal receptors to low-chloride solutions. Eur. Respir. J. (1993) 6:1151-1155.
75. VENTRESCA P, NICHOL GM, BARNES PJ, CHUNG KF: Inhaled furosemide inhibits cough induced by low chloride content solutions and not by capsaicin. Am. Rev. Respir. Dis. (1990) 142:143-146.
76. SUDO T, HAYASHI F, NISHINO T: Responses of tracheobronchial receptors to inhaled furosemide in anesthetized rats. Am. J. Repir. Crit. Care Med. (2000) 162:971-975.
77. CHUNG KF, BARNES PJ: Loop diuretics and asthma. Pulm. Pharmacol. (1992) 5:1-7.
78. B receptors in the lung. Trends Pharmacol. Sci. (1993) 14:26-29.
79. BOLSER DC, DEGENNARO FC, O'REILLY S et al.: Peripheral and central sites of action of GABA-B agonists to inhibit the cough reflex in the cat and guinea-pig. Br. J. Pharmacol. (1994) 113 1344-1348.
80. DICPINIGAITIS PV, DOBKIN JB, RAUF K, ALDRICH TK: Inhibition of capsaicin-induced cough by the γ-aminobutyric acid agonist baclofen. J. Clin. Pharmacol. (1998) 38:364-367.
81. DICPINIGAITIS PV, DOBKIN JB: Antitussive effect of the GABA-agonist baclofen. Chest (1997) 111:996-999.
82. HANSSON L, MIDGREN B, KARLSSON JA:. Effects of inhaled lignocaine and adrenaline on capsaicin-induced cough in humans. Thorax (1994) 49:1166-1168.
83. CHOUDRY NB, FULLER RW, ANDERSON N, KARLSSON JA: Separation of cough and reflex bronchoconstriction by inhaled local anaesthetics. Eur. Respir. J. (1990) 3:579-583.
84. HOWARD P, CAYTON RM, BRENNAN SR, ANDERSON PB: Lignocaine aerosol and persistent cough. Br. J. Dis. Chest (1977) 71 19-24.
85. ADCOCK JJ, DOUGLAS GJ, GARABETTE M et al.: RSD931, a novel anti-tussive agent acting on airway sensory nerves. Br. J. Pharmacol. (2003) 138:407-416.
86. KAMEI J, HOSOKAWA T, YANAURA S, HUKUHARA T: Involvement of central serotonergic mechanisms in the cough reflex. Jap. J. Pharmacol. (1986) 42:531-538
87. STONE RA, WORSDELL YM, FULLER RW, BARNES PJ: Effects of 5-hydroxytryptamine and 5-hydroxytryptophan infusion on the human cough reflex. J. Appl. Physiol. (1993) 74:396-401.
88. 1A receptor agonist, 8-OH-DPAT on cough responses in the conscious guinea-pig. Eur. J. Pharmacol. (1997) 332:201-207.
89. CHUNG KF: Methods of assessing cough and antitussives in man. Pulm. Pharmacol. (1996) 9:373-377.
90. BIRRING SS, PRUDON B, CARR AJ, SINGH SJ, MORGAN MD, PAVORD ID: Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax (2003) 58:339-343.